G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.
about
G Protein-Coupled Receptor Kinases: Crucial Regulators of Blood PressurePersonalized medicine and treatment approaches in hypertension: current perspectivesAssociation between GRK4 and DRD1 gene polymorphisms and hypertension: a meta-analysisGastrorenal Axis.Common variants of the G protein-coupled receptor type 4 are associated with human essential hypertension and predict the blood pressure response to angiotensin receptor blockade.The renal dopaminergic system: novel diagnostic and therapeutic approaches in hypertension and kidney disease.Obesity-associated hypertension: recent progress in deciphering the pathogenesisProgress and future aspects in genetics of human hypertensionThe importance of G protein-coupled receptor kinase 4 (GRK4) in pathogenesis of salt sensitivity, salt sensitive hypertension and response to antihypertensive treatment.Structure and Function of the Hypertension Variant A486V of G Protein-coupled Receptor Kinase 4The evolving impact of g protein-coupled receptor kinases in cardiac health and diseaseHypertension pharmacogenomics: in search of personalized treatment approachesGenomics and Pharmacogenomics of Salt-sensitive HypertensionPharmacogenetics and cardiovascular disease--implications for personalized medicineThe effects of genes implicated in cardiovascular disease on blood pressure response to treatment among treatment-naive hypertensive African Americans in the GenHAT study.An update on the pharmacogenetics of treating hypertension.Pharmacogenomics considerations in the control of hypertension.Primary Pediatric Hypertension: Current Understanding and Emerging Concepts.High Frequency of Variants of Candidate Genes in Black Africans with Low Renin-Resistant Hypertension.α1 -Adrenoceptor activation of PKC-ε causes heterologous desensitization of thromboxane receptors in the aorta of spontaneously hypertensive rats.Effect of GRK4 genetic variants on blood pressure response to atenolol and cardiovascular outcomes.Increased renal oxidative stress in salt-sensitive human GRK4γ486V transgenic mice.Two Fatal Cases Involving Cardiovascular Drugs Diltiazem and Amlodipine.Genomics and Pharmacogenomics of Salt-sensitive Hypertension.
P2860
Q26743885-2DB532FE-5D02-4E30-9113-0DD33117F990Q26751135-22E6962F-3815-460D-9E2B-282DD67791E7Q28077005-10FEF7A2-CEB8-4E4C-8BF7-BCA0E51CC34CQ30277035-8D3A2090-3C99-49D2-90B0-B51E00B68085Q30300484-FD1999C8-D7FA-4AA6-BF5A-FB1FF1082E42Q30360038-CC0C0960-9951-40EB-8430-9118A70ACF72Q34287762-213DCF29-9384-4E1C-A8AF-00EB1A65690EQ35202339-0924CD0B-FCD0-4DE3-948C-D64F06802D3EQ35381351-06DBD565-DC6A-46CF-B4CD-ABE7DB8C408CQ35953146-065CC82E-6DCF-4DFB-A6C3-3186C2D98DB4Q36000382-6830A5F8-41CC-4799-8701-56DF2400C875Q36652960-95FB88D5-5D45-43C7-A06C-1D73CF01A893Q36923553-908FE688-C7F5-4312-A25D-BC61F7BD3D0EQ36974672-BCFC9E67-4520-4CE2-A372-30D3EE69C3CEQ37116230-37B35A89-61F8-4E5E-8A35-FE179E7BAE73Q38263731-3255F7BC-80C2-4AD9-A735-FA145B18DDDFQ38629883-C92B0DB7-BDF8-4FC3-AD10-4DF23E43839DQ40105112-6423D814-2F71-4084-B632-1CBBE70019B0Q40396184-8570888F-3D92-48C7-B06B-770BFCBC9272Q42356377-1A1418B4-327D-42A0-81FB-A88BA09CA050Q43994303-C1F4E340-E1B7-44AB-B608-EB692B9C4999Q46419015-99C24C71-0B79-4C96-9C73-F56515A23113Q49999844-6C240356-AD02-4587-A937-5B0CD060E48CQ55076287-96F96412-B810-44D5-922C-E5DD9B658DCD
P2860
G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
G protein receptor kinase 4 po ...... ated outcomes in hypertension.
@ast
G protein receptor kinase 4 po ...... ated outcomes in hypertension.
@en
type
label
G protein receptor kinase 4 po ...... ated outcomes in hypertension.
@ast
G protein receptor kinase 4 po ...... ated outcomes in hypertension.
@en
prefLabel
G protein receptor kinase 4 po ...... ated outcomes in hypertension.
@ast
G protein receptor kinase 4 po ...... ated outcomes in hypertension.
@en
P2093
P2860
P1433
P1476
G protein receptor kinase 4 po ...... ated outcomes in hypertension.
@en
P2093
Alexander G Vandell
Amber L Beitelshees
Arlene B Chapman
Brian E Gawronski
Carl J Pepine
John G Gums
Julie A Johnson
Kent R Bailey
Maximilian T Lobmeyer
Rhonda M Cooper-DeHoff
P2860
P304
P356
10.1161/HYPERTENSIONAHA.112.198721
P407
P577
2012-09-04T00:00:00Z